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Abstract: In this study, liposomes coated with cationic polymers, poly-L-arginine (PLA), 
were assessed as a promising gene transfer system in human cervical carcinoma (HeLa) cells 
and human hepatoma cell line (Huh7) cells. The liposomes were prepared using egg yolk 
phosphatidylcholine and sodium oleate in the molar ratio of 10:2 with an ultrasonic generator 
and then coated with PLA. The PLA-coated liposomes (PCLs) formed complexes with plasmid 
DNA encoding green fluorescent protein. The complexes were characterized by agarose gel 
electrophoresis and investigated for their transfection efficiency in HeLa and Huh7 cells. The 
data were compared with PLA/DNA complexes and the positive control Lipofectamine 2000TM. 
The results showed that complete PCL/DNA complexes were formed at weight ratios of more 
than 0.05. Efficient gene transfer by PCLs was dependent on the cell type. The transfection 
efficiency of PCLs was about two times higher than that of PLA/DNA complexes in both 
HeLa cells and Huh7 cells. Cytotoxicity was determined by the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide assay and showed that 80%–100% of both of the cells were 
viable after treating PCL/DNA complexes. The present results demonstrate that PCLs are a 
promising, nonviral gene carrier with low toxicity.
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Introduction
Efficient and safe gene transfer systems are the fundamental basis for gene therapy, 
as well as for many other laboratory applications.1 Cationic polymers and liposomes 
are widely used for nonviral gene delivery.2,3 Cationic liposomes form a complex with 
anionic DNA molecules and are hypothesized to deliver DNA through the endosomal 
pathway. The cationic liposomal system, however, has the disadvantages of low 
  efficiency of transfection due to DNA degradation in lysosomes and high cytotoxicity. 
Therefore, there has been an intense effort to develop cationic lipid/DNA complexes 
(lipoplexes) that efficiently transfer genes. These efforts have included the synthesis of 
new cationic lipids,4 the development of new formulations of existing cationic lipids,5,6 
and the addition of third components, such as a polycation or cationic peptide.7–12
Cationic polypeptides have been extensively used as tools for gene carriers. 
The main reason for using cationic polypeptides is that cationic polymer vectors 
  provide flexible DNA-carrying capacity and are simple to use. The nature of the 
basic peptide in efficient protein transduction and in nucleic acid binding prompted 
us to explore the possibility of DNA transfection by these peptides.13 From the study 
of polypeptide/DNA complexes, the physicochemical properties and the transfection 
efficiency of the complexes correlated to the type and molecular weight (MW) of 
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the polypeptide. In addition, it has been reported that the 
  biological activities of the transfection reagents are highly 
associated with their physicochemical properties.14,15 For 
example, various types and MW of polypeptides, weight 
ratios, and pH of transfection medium were demonstrated 
to influence the physicochemical properties and transfection 
efficiency of polypeptide/DNA complexes.16–19
Recently, some peptide sequences, known as protein 
transduction domains or membrane translocalization signals, 
were identified and introduced for the delivery of plasmid 
DNA.20,21 Interestingly, it is known that these sequences 
usually contain positively charged amino acid residues, such 
as arginine and lysine, which have been reported to be able 
to enhance transportation into cells.13,22 Additionally, oligo-
arginine conjugates demonstrated characteristics similar 
to cell-penetrating peptides in cell translocation, and the 
transfection efficiency in human cervical carcinoma (HeLa) 
cells was highly improved by conjugating oligo-arginine to 
PEG-ylated lipids.23 A polyamidoamine dendrimer conju-
gated with L-arginine also showed enhanced gene delivery 
compared with the native dendrimer.24
Previously, we investigated the effect of cationic 
polypeptides (poly-L-lysine, poly-L-arginine [PLA], and 
poly-L-ornithine) mixed with chitosan (CS) on in vitro 
transfection efficiency and cytotoxicity in HeLa cells.25 The 
high transfection efficiency was dependent on the type and 
MW of the polypeptides, the weight ratio, and the order 
of mixing. Among the carriers, PLA showed the highest 
transfection efficiency. The highest transfection efficiency, 
observed in ternary complexes of PLA/DNA/CS at the 
weight ratio of 2:1:4, was significantly higher than that of 
PLA/DNA complexes (2.4 times) and CS/DNA complexes 
(47 times). Therefore, in this study, we intended to develop 
an effective nonviral gene transfer system by combining 
the advantages of both liposomes and   polycations. The 
polycation liposomes were prepared by coating lipo-
somes with PLA and then complexing with DNA. Their 
physicochemical properties, such as complex formation, 
particle size, and zeta potential, were also investigated. 
A number of variables influencing transfection efficiency 
and cytotoxicity, including carrier/DNA weight ratio, cell 
types (HeLa and Huh7 cells), and serum in transfection 
medium, were investigated.
Materials and methods
Materials
PLA with an average MW of .70 kDa, sodium oleate (NaO), 
and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl   tetrazolium 
bromide (MTT) were purchased from   Sigma-Aldrich 
(St Louis, MO). Polyethylenimine (PEI; MW 25 kDa) was 
purchased from Aldrich (Milwaukee, WI). Egg yolk phos-
phatidyl choline (EPC) was purchased from Wako Pure 
Chemical (Osaka, Japan). Minimum Essential Medium 
Eagle (MEM), Roswell Park Memorial Institute (RPMI), 
Trypsin-EDTA, penicillin and streptomycin antibiotics, 
fetal bovine serum (FBS), and Lipofectamine 2000TM were 
obtained from GIBCO-Invitrogen (Grand Island, NY). The 
pEGFP-C2 plasmid DNA encoding green fluorescent pro-
tein (GFP) was obtained from Clontech (Palo Alto, CA). 
The λDNA/HindIII marker was obtained from Promega 
(Madison, WI). Huh7 cells and HeLa cells were obtained 
from American Type Culture Collection (Rockville, MD). 
All other chemicals were of cell culture and molecular 
biology quality.
Plasmid preparation
pEGFP-C2 was propagated in Escherichia coli DH5-α and 
purified using the Qiagen endotoxin-free plasmid purifica-
tion kit (Qiagen, Santa Clarita, CA). DNA concentration was 
quantified by the measurement of UV absorbance at 260 nm 
using a GeneRay UV Photometer (Biometra). The purity of 
the plasmid was verified by gel electrophoresis (0.8% agarose 
gel) in Tris acetate-EDTA (TAE) buffer pH 8.0 using λDNA/
HindIII as the DNA marker.
Preparation of PLA-coated liposomes
Anionic liposomes composed of EPC:NaO (10:2 molar 
ratio) were prepared by sonication. Briefly, EPC and NaO 
were separately dissolved in chloroform:methanol (2:1 v/v). 
The materials were deposited in a test tube, and the solvents 
were evaporated under nitrogen gas flow. The lipid film 
was placed in a desiccator connected to a vacuum pump for 
6 hours to remove remaining organic solvents. The dried 
lipid film was hydrated with Tris buffer (20 mM Tris and 
150 mM NaCl, pH 7.4). Following hydration, the dispersion 
was sonicated in a bath sonicator for 10 minutes and then 
in a probe sonicator for two cycles of 30 minutes each. For 
PLA-coated liposomes (PCLs), the liposomes were mixed 
with PLA solution (1 mg/mL) at the ratio of 1:1 (w/w) with 
a magnetic stirrer for 30 minutes.
Preparation of complexes
The PLA/DNA and PCL/DNA complexes were prepared at 
various weight ratios of 1, 2, 2.5, 3, and 4 by adding 1 µg of 
DNA (pEGFP-C2) solution to the PLA or PCL solution. The 
mixture was gently mixed using a pipette for 3–5 seconds to 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2246
Opanasopit et alInternational Journal of Nanomedicine 2011:6
initiate complex formation and left for 15 minutes at room 
temperature.
Characterization of complexes
The complex formation was confirmed by electrophoresis 
(MyRun Intelligent, Cosmo Bio, Japan). Agarose gels were 
prepared with 0.7% agarose in TAE buffer with ethidium 
bromide (0.5 µg/mL). The electrophoresis was carried out for 
60 minutes at 100 V . The volume of the sample loaded in the 
well was 15 µL of the complex containing 1 µg of DNA.
Size and zeta potential measurements
The particle size and surface charge of PLA/DNA complexes 
and PCL/DNA complexes were determined by photon cor-
relation spectroscopy using a Zetasizer Nano ZS (Malvern 
Instruments Ltd, Malvern, UK) at room temperature. The 
complexes were diluted with distilled water that had been 
passed through a 0.22 µm membrane filter prior to use. All 
samples were measured in triplicate.
In vitro transfection studies using  
cell cultures
HeLa and Huh7 cells were maintained in MEM and RPMI 
at pH 7.4, supplemented with 10% FBS, 2 mM L-glutamine, 
and 1% nonessential amino acid solution in a humidified 
atmosphere (5% CO2, 95% air, 37°C). The cells were grown 
under standard conditions until 60%–70% confluency. The 
cells were seeded into a 24-well plate at a density of 2 × 104 
cells/well and grown for 24 hours. PLA/DNA and PCL/
DNA complexes were suspended in a serum-free medium 
and incubated for 30 minutes at room temperature. Prior 
to transfection, the culture medium was removed, and the 
cells were rinsed with phosphate-buffered saline (PBS, pH 
7.4) and then supplied with complex solutions at various 
weight ratios. The cells were incubated with complexes for 
24 hours at 37°C under a 5% CO2 atmosphere, then washed 
with PBS once and grown in culture medium for 24 hours. 
For the fluorescence assay, the cells were directly viewed 
under a fluorescence microscope (model: GFP-B, wave-
lengths: excitation filter 480/40 and emission filter 535/50). 
The transfection efficiency was calculated by the number 
of transfected cells per unit area of a 24-well tissue culture 
plate (1.9 cm2).
Cytotoxicity studies
MTT is a tetrazolium salt that is cleaved into a dark blue 
product by mitochondrial dehydrogenases in living but not 
dead cells.26 HeLa and Huh7 cells were seeded at a   density 
of 8 × 103 cells/well in 96-well cell culture plates and 
  preincubated for 24 hours before PLA and PCL treatment. 
The cells were then treated with PLA and PCL at various 
  concentrations (0.001–1 mg/mL) in serum-free medium, pH 
7.4 for 24 hours. Dilutions of PLA and PCL were made using 
serum-free medium to ensure that the cells did not die from 
nutrition deficiency. The PLA/DNA and PCL/DNA com-
plexes were supplied in the same concentrations as used in the 
in vitro transfection experiment. After treatment, the samples 
were removed, fresh cell culture medium was added, and the 
cells were incubated for 24 hours to stabilize. Finally, the 
cells were incubated with 100 µL MTT-containing medium 
(0.1 mg/mL MTT in serum-free medium) for 4 hours. Then, 
the medium was removed, and the formazan crystals formed 
in the living cells were dissolved in 100 µL dimethyl sul-
foxide. The relative viability (%) was calculated based on 
absorbance at 550 nm using a microplate reader (Universal 
Microplate Analyzer, Models AOPUS01 and AI53601, 
Packard BioScience, CT). Viability of nontreated control 
cells was arbitrarily defined as 100%.27
Statistical analysis
All experimental measurements were collected in triplicate. 
The values are expressed as the mean ± standard deviation 
(SD). Statistical significance of differences in cell viability 
were examined using one-way analysis of variance (ANOVA) 
followed by Fisher’s Least Significant Difference (LSD) test. 
The significance level was set at P , 0.05.
Results and discussion
Characterization of PCL/DNA complexes
To determine the optimal complexation conditions, it was 
necessary to evaluate the degree of binding between either 
PCL or DNA at different weight ratios. The formation of 
complexes between PCL and the pEGFP-C2 plasmid DNA 
was visualized by agarose gel electrophoresis. To vary the 
weight ratio of each complex, the PLA or PCL fraction was 
changed while the DNA concentration was kept constant. 
The complex formation between the carrier and DNA was 
found to depend on the weight ratio (Figure 1). When the 
concentration of the carrier gradually increased, the DNA 
was increasingly retained within the gel loading well. 
Migration of the DNA on the agarose gel was retarded, 
resulting from the charge neutralization of the complexes. 
Relative cell viability=
(OD   OD )   100 550,sample 550,blank −×    
(OD   OD ) 550,control 550,blank −
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The complexes had completely formed when the DNA was 
totally retained within the well. The complete complexation 
of PLA/DNA was successful at weight ratios above 0.1, 
whereas PCL/DNA was formed above 0.05. These results 
revealed that the PCL had a stronger binding affinity for 
DNA than did PLA.
The particle size and zeta potential of PLA/DNA and 
PCL/DNA complexes at various weight ratios were deter-
mined and plotted against the weight ratios of the PLA/DNA 
(Figure 2A) and PCL/DNA complexes (Figure 2B). The 
particle sizes of the PLA/DNA complexes at weight ratios 
from 1 to 3 were in the range of 200 nm to 700 nm, which is 
slightly smaller than those seen for the PCL/DNA complexes 
at weight ratios from 1 to 8 (400 nm to 1000 nm). The particle 
size of both complexes decreased with increasing weight 
ratio (Figure 2). This finding was due to the intermolecular 
cross-linking between the DNA strands by self-aggregates, 
which is a phenomenon typically observed with either high 
DNA concentrations or excess polycations.
The zeta potential is a function of the surface charge 
that develops when any material is placed in a liquid and 
is a good index of the electrostatic properties of colloidal 
particles.28 An initial negative value of the zeta potential 
was observed for anionic liposomes (PC/NaO). On the other 
hand, the PCL at 1:1 (w/w) showed positive zeta potentials. 
The zeta potentials of the PCL/DNA complexes were found 
to increase with increasing weight ratio of PCL due to the 
higher density of protonated amines in the PCL. A similar 
result was observed in PLA (Figure 2A).
In vitro transfection
The achievement of high gene transfection efficiency is 
a final goal for the development of novel gene carriers. 
To investigate the PLA- and PCL-mediated gene trans-
fection efficiencies, an in vitro gene transfection assay 
was performed with HeLa cells and Huh7 cells using the 
pEGFP-C2 plasmid encoding GFP. PCL formulations 
were prepared using anionic liposomes (EPC: NaO in 
the molar ratio of 10:2) and then coated with PLA at the 
weight ratio of 1:1.
To investigate the optimum conditions for gene transfec-
tion, PLA and PCL were complexed with DNA at various 
weight ratios of 1, 1.5, 2, 3, and 4. PEI and Lipofectamine 
2000 complexed with DNA in the weight ratios of 1 and 2, 
respectively, were used as the positive controls. In all stud-
ies, there was no transfection in the controls (cells without 
complexes) or naked DNA. The results of transfection 
efficiency for PLA and PCL are shown in Figure 3. The 
transfection efficiencies increased up to a maximum when 
the weight ratio increased, then decreased with further 
A 7 56 4 3 2 18    7 56 4 3 2 18    B
Kb
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Figure 1 gel retardation analysis of (A) poly-L-arginine (PLA)/DNA complexes and (B) PLA-coated liposomes (PCL)/DNA complexes: lane 1, λHind III DNA marker; lane 
2, pEgFP-C2 plasmid; lanes 3–8, carrier/DNA complexes at weight ratios of 0.001, 0.005, 0.01, 0.05, 0.1, and 0.5, respectively.
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Figure  2  Zeta  potential  (□)  and  particle  size  (♦)  at  varying  weight  ratios  of 
complexes formulated with (A) poly-L-arginine (PLA)/DNA and (B) PLA-coated 
liposomes (PCL)/DNA. 
Note: Each value represents the mean ± SD of three measurements.
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Figure 3 Transfection efficiencies of complexes formulated with (■)poly-L-arginine (PLA)/DNA and (□) PLA-coated liposomes (PCL)/DNA in (A) human cervical carcinoma 
cells and (B) human hepatoma cell line cells. 
Note: Each value represents the mean ± SD of three wells. *Difference values were statistically significant (P , 0.05).
incremental changes to this ratio. In both cells (HeLa and 
Huh7), the PCL formulations were much more effective 
for gene transfer than the conventional polyplexes (PLA/
DNA complexes). In the HeLa cells, the highest transfection 
efficiency of the PCL/DNA complexes at a weight ratio of 
2 was 808.95 ± 138.59 cell/cm2. For comparison, the high-
est transfection efficiency of the PLA/DNA complexes at a 
weight ratio of 4 was 543.86 ± 22.34 cell/cm2. PCL showed a 
1.5 times higher gene expression than the polyplex prepared 
with the same polymer (PLA) (Figure 3A). In the Huh7 cells, 
PCL showed the highest transfection efficiency at a weight 
ratio of 1.5 (304.74 ± 9.52 cell/cm2), which is approximately 
two times higher than that of PLA at the weight ratio of 1.5 
(153.16 ± 1.8 cell/cm2).
Polypeptide liposomes have been hypothesized to be 
promising transfection agents. Liposomes modified with 
peptide have also shown remarkable transfection efficiency, 
including oligopeptide/cholesterol derivatives (DMB-
Chol), oligopeptide/dioleoyl-phosphatidylethanolamine 
(DOPE), poly-L-lysine/DC-chol/DOPE liposomes, peptide 
ligand-EPC lipids, NLS peptide-DOSPA (cationic lipid), 
and NLS peptide-DOPE (neutral lipid).29,30 Furthermore, 
previous studies reported that the transfection efficiency of 
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Figure 4 Comparison of the transfection efficiencies of poly-L-arginine (PLA)/DNA 
and PLA-coated liposomes (PCL)/DNA complexes in human cervical carcinoma cells 
with (□) 10% serum and (■) without serum in the transfection reagent.
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cationic liposomes was dependent on the serum. As shown 
in   Figure 4, the PLA- and PCL-associated gene expres-
sions were inhibited by the presence of 10% serum. For 
example, Oku et al31 also reported that in the presence of 
serum, PCL composed of PC and cetylated polyethylenimine 
had an enhanced gene transfer over PCL without serum. 
On the contrary, the efficiency of DOTAP liposomes or 
Lipofectamine was markedly suppressed in the presence 
of serum. To clarify the serum activation of PCL-mediated 
transfection, the authors examined the formation of DNA/
PCL complexes under a microscope. The PCL and DNA 
appeared as rather heterogeneous aggregates in the absence 
of serum but formed smaller and more homogeneous com-
plexes in the presence of serum. Besides lipoplex size, 
many other parameters (eg, cationic lipids, cell type, and in 
vivo or in vitro environments) may also result in different 
transfection efficiencies.
Cytotoxicity
One of the major requirements of cationic vectors for gene 
delivery is low cytotoxicity. However, cationic polymers 
have been known to be cytotoxic materials. It is believed 
that the cytotoxic effect mainly originates from the inher-
ent cationic charge, leading to polymer aggregation on cell 
surfaces, which impairs important membrane functions. 
The toxicity of cationic polymers is different depending on 
the polymer, the MW of the polymer, and the type of cells 
studied. Therefore, PEI, PLA, PCL, and their complexes 
with DNA at various weight ratios were investigated in this 
study for their cytotoxicities in HeLa and Huh7 cells. The 
half maximal inhibitory concentration (IC50) values of PEI, 
PLA, and PCL in both cells are shown in Table 1. The higher 
IC50 values indicated lower cytotoxicity for these complexes. 
Interestingly, the results revealed that the cytotoxicity in the 
HeLa cells was more than that in the Huh7 cells and that 
PLA had lower cytotoxicity than PEI in both cell lines. These 
activities might be the result of the biodegradability of PLA. 
In addition, the IC50 values of PCL were higher than those of 
PLA. Although the exact mechanism remains unclear, it is 
possible that the liposomes might increase the cell viability 
of PLA. This finding was similar to our previous study32 and 
also a study by Hu et al,33 who revealed that lipopolyplexes 
helped to decrease the cytotoxicity.
The cytotoxicity of PLA and PCL complexes with DNA 
at various weight ratios in the transfection experiments was 
performed in HeLa and Huh7 cells. Figure 5 shows the effects 
of the PLA/DNA and PCL/DNA complexes on cell viability. 
When the cells were incubated with 1 µg of naked DNA, 
the cell viability remained almost the same as the control 
(nontransfected cells). Their average cell viability decreased 
when the carrier/DNA weight ratios increased. However, 
the viability was over 80% at the weight ratio of 2 (highest 
transfection). Therefore, this study clearly showed that PCL 
Table  1  Cytotoxicity  (half  maximal  inhibitory  concentration 
[IC50]) of polyethylenimine (PEI), poly-L-arginine (PLA), and PLA-
coated liposomes in human hepatoma cell line (huh7) and human 
cervical carcinoma (heLa) cells
Samples IC50 (μg/mL)
Huh7 cells HeLa cells
PEI MW 25 kDa 
PLA MW .70 kDa 
PLA MW .70 kDa  
coated liposomes
54.1 
70.0 
70.3
1.7 
5.5 
10.6
Abbreviation: MW, molecular weight.
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Figure 5 Comparison of the cell viability of (■)poly-L-arginine (PLA)/DNA and (□) PLA-coated liposomes (PCL)/DNA complexes at various weight ratios in (A) human 
cervical carcinoma cells and (B) human hepatoma cell line cells. 
Note: Each value represents the mean ± SD of three wells. *Difference values were statistically significant (P , 0.05).
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is safe, which is similar to the finding from a previous study.32 
Moreover, the PCLs were found to be an efficient gene deliv-
ery system that helped to increase cell viability.
Conclusion
PCLs were successfully used to improve transfection effi-
ciencies of PLA. The ability of these novel PCLs to transfer 
functionally active DNA into the cell culture was found to 
be dependent upon the weight ratio and cell type. The trans-
fection efficiency of the PLC was about two times higher 
than that of the PLA. This study suggested that PCLs are 
safe and significantly improve the gene delivery capability 
in vitro. These lipopolyplexes might also be useful for gene 
delivery.
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